Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Myelin in multiple sclerosis is developmentally immature.
M A Moscarello, … , C Ackerley, C Boulias
M A Moscarello, … , C Ackerley, C Boulias
Published July 1, 1994
Citation Information: J Clin Invest. 1994;94(1):146-154. https://doi.org/10.1172/JCI117300.
View: Text | PDF
Research Article Article has an altmetric score of 9

Myelin in multiple sclerosis is developmentally immature.

  • Text
  • PDF
Abstract

The etiology of multiple sclerosis (MS) is considered to involve genetic, environmental, infective, and immunological factors which affect the integrity of a normally assembled myelin sheath, either directly or indirectly resulting in demyelination. In a correlative study involving protein chemical, mass spectrometric, and electron microscopic techniques we have determined that myelin obtained from victims of MS is arrested at the level of the first growth spurt (within the first 6 yr of life) and is therefore developmentally immature. The data supporting this conclusion include (a) the pattern of microheterogeneity of myelin basic protein (MBP); (b) the NH2-terminal acylation of the least cationic component of MBP ("C-8"); (c) the phase transition temperature (Tc) of myelin isolated from victims of MS correlated with the increased proportion of the least cationic component of MBP; and (d) immunogold electron microscopy using an antibody specific for "C-8" showed that the distribution of gold particles in a 2-yr-old infant was similar to the distribution found in a victim of MS. We postulate that this developmentally immature myelin is more susceptible to degradation by one or a combination of factors mentioned above, providing the initial antigenic material to the immune system.

Authors

M A Moscarello, D D Wood, C Ackerley, C Boulias

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1960 Total
Citations: 1 3 7 3 9 10 9 6 13 11 6 5 17 16 13 13 7 12 9 15 9 7 11 6 5 8 7 3 4 7 1 1 254
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2013 (17)

Title and authors Publication Year
Deimination restores inner retinal visual function in a demyelinating disease
Mabel Enriquez-Algeciras, Di Ding, Fabrizio Mastronardi, Robert Marc, Vittorio Porciatti, Sanjoy Bhattacharya
Journal of Clinical Investigation 2013
Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue DiseasesPossibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue Failure
MA Karsdal, MJ Nielsen, JM Sand, K Henriksen, F Genovese, AC Bay-Jensen, V Smith, JI Adamkewicz, C Christiansen, DJ Leeming
ASSAY and Drug Development Technologies 2013
Peptidylarginine deiminase and protein citrullination in prion diseases
B Jang, A Ishigami, N Maruyama, RI Carp, YS Kim, EK Choi
Prion 2013
Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD)
VL Bonilha, KG Shadrach, ME Rayborn, Y Li, GJ Pauer, SA Hagstrom, SK Bhattacharya, JG Hollyfield
Experimental Eye Research 2013
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment
JL Huynh, P Casaccia
The Lancet Neurology 2013
Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms
G Harauz, JM Boggs
Journal of Neurochemistry 2013
Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex
AP Nicholas
Neuroscience Letters 2013
Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis
S Wang, Y Wang
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2013
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model
L Wei, E Wasilewski, SK Chakka, AM Bello, MA Moscarello, LP Kotra
Journal of Medicinal Chemistry 2013
Myelin-specific proteins: A structurally diverse group of membrane-interacting molecules
H Han, M Myllykoski, S Ruskamo, C Wang, P Kursula
BioFactors 2013
Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes
AM Bello, E Wasilewski, L Wei, MA Moscarello, LP Kotra
ACS Medicinal Chemistry Letters 2013
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering
AN Hegde
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering 2013
Lipid Membrane Association of Myelin Proteins and Peptide Segments Studied by Oriented and Synchrotron Radiation Circular Dichroism Spectroscopy
G Muruganandam, J Bürck, AS Ulrich, I Kursula, P Kursula
The Journal of Physical Chemistry B 2013
Specific biotinylation and sensitive enrichment of citrullinated peptides
AE Tutturen, A Holm, B Fleckenstein
Analytical and Bioanalytical Chemistry 2013
Methods for the Detection of Peptidylarginine Deiminase (PAD) Activity and Protein Citrullination
SM Hensen, GJ Pruijn
Molecular & cellular proteomics : MCP 2013
Functional Roles of the Non-Catalytic Calcium-Binding Sites in the N-Terminal Domain of Human Peptidylarginine Deiminase 4
YL Liu, IC Tsai, CW Chang, YF Liao, GY Liu, HC Hung, DS Sem
PloS one 2013
Citrullination – small change with a great consequence
M Gogól
Folia Biologica et Oecologica 2013

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
119 readers on Mendeley
1 readers on CiteULike
See more details